Method of treating disorders of the cardiovascular system and a pharmaceutical agent
Abstract
A method of treating a pathological syndrome includes administration of an activated form of ultra-low doses of antibodies to an antigen, wherein said activated form is obtained by repeated consecutive dilution combined with external impact, and the antigen is a substance or a pharmaceutical agent exerting influence upon the mechanisms of formation of this particular pathological syndrome. Pharmaceutical agent for treating a pathological syndrome contains activated form of ultra-low doses of monoclonal, polyclonal or natural antibodies to an antigen, wherein said activated form is prepared by means of repeated consecutive dilution and external treatment, predominantly based on homeopathic technology, and said antigen is a substance or a drug acting as a direct cause of the pathological syndrome or involved in regulation of mechanisms of its formation. At that, activated forms of ultra-low doses of antibodies are raised against antigens of exogenous or endogenous origin, against autologous antigens, fetal antigens; anti-idiotypic antibodies are used too.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . A method of treating disorders of the cardiovascular system in a patient, said method comprising administering to said patient a homeopathically potentized form of at least one antibody to an antigen, which antigen is a molecule capable of regulating cardiovascular disorders.
18 . (canceled)
19 . The method of claim 17 , wherein the antigen is an exogenous molecule.
20 . The method of claim 17 , wherein the antigen is a hapten.
21 .- 31 . (canceled)
32 . The method of claim 17 , wherein the antigen is verapamil.
33 .- 36 . (canceled)
37 . The method of claim 17 , wherein the disorder of the cardiovascular system is ischemic heart disease.
38 . The method of claim 17 , wherein the disorder of the cardiovascular system is angina.
39 . The method of claim 17 , wherein the disorder of the cardiovascular system is tachycardia.
40 . The method of claim 17 , wherein the disorder of the cardiovascular system is bradyarrhythmia.
41 . The method of claim 17 , wherein the disorder of the cardiovascular system is cardiac failure.
42 . The method of claim 17 , wherein the disorder of the cardiovascular system is rheumatic heart disease.
43 . The method of claim 17 , wherein the disorder of the cardiovascular system is cardiac arrhythmia.
44 . The method of claim 17 , wherein the disorder of the cardiovascular system is ventricular extrasystoles.
45 . The method of claim 17 , wherein the disorder of the cardiovascular system is atrial extrasystoles.
46 . The method of claim 17 , wherein the disorder of the cardiovascular system is myocardiopathy.Join the waitlist — get patent alerts
Track US2016184256A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.